Advanced Oncotherapy plc (AVO.L)
- Previous Close
1.9250 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0870 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
10.445M - Beta (5Y Monthly) 0.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date Feb 13, 2024 - Feb 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
www.avoplc.comRecent News: AVO.L
Performance Overview: AVO.L
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVO.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVO.L
Valuation Measures
Market Cap
10.44M
Enterprise Value
67.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.17
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-2.77
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-11.73%
Return on Equity (ttm)
-67.34%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-32.6M
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
2.51M
Total Debt/Equity (mrq)
98.71%
Levered Free Cash Flow (ttm)
-34.96M